ProfessorMaria Kyrgiou
Chair in Gynaecologic Oncology
Department of Metabolism, Digestion and Reproduction - Faculty of Medicine
Orcid identifier0000-0002-7165-0735 (opens in a new tab)
- Chair in Gynaecologic OncologyDepartment of Metabolism, Digestion and Reproduction - Faculty of Medicine
- 020 7594 2177 (Work)
- Institute of Reproductive and Developmental Biology, Hammersmith Campus, United Kingdom
RESEARCH
Overview
The primary focus of her research is traslational research in gynaecological diseases and cancers, in particular cervical, endometrial and ovarian cancer with an emphasis on prevention and personalised treatment.
She has an interest in cervical pre-invasive and invasive disease, primary cervical screening and HPV vaccines. She has led research into the impact of treatment for cervical pre-invasive and early invasive cervical disease on reproductive outcomes and the clinical use of HPV biomarkers in personalising the management of women with abnormal findings at primary population-based screening.
She runs a research group investigating the impact of obesity and metabolic disorders in the development of gynaecological cancers with an emphasis on endometrial cancer.
She further investigates the role of the genital tract and gut microbiome and host interactions in the development and treatment response of gynaecological cancers.
The primary focus of her research is traslational research in gynaecological diseases and cancers, in particular cervical, endometrial and ovarian cancer with an emphasis on prevention and personalised treatment.
She has an interest in cervical pre-invasive and invasive disease, primary cervical screening and HPV vaccines. She has led research into the impact of treatment for cervical pre-invasive and early invasive cervical disease on reproductive outcomes and the clinical use of HPV biomarkers in personalising the management of women with abnormal findings at primary population-based screening.
She runs a research group investigating the impact of obesity and metabolic disorders in the development of gynaecological cancers with an emphasis on endometrial cancer.
She further investigates the role of the genital tract and gut microbiome and host interactions in the development and treatment response of gynaecological cancers.
GRANTS
- STANDARD - CALLImperial College Medical Technologies Overarching New Entreprise (MedTechONE)Wellcome Trust1 Jul 2022 - 30 Jun 2026
- STANDARD - CALLMRC UKRI IAA 22-25Medical Research Council (MRC)1 Apr 2022 - 31 Mar 2027